Harvoni registers its name in the pharmaceutical patent list

Published: 2016-01-25 14:58:14

Updated: 2016-01-25 14:58:14

Harvoni Tab(sofosbuvir, ledipasvir), a hepatitis C treatment, register its name in the pharmaceutical patent list.

In the Ministry of Food and Drug Safety’s ‘Pharmaceutical Patent List,’ Gilead Sciences Korea was known to register the two products of Harvoni Tab on the 20^th.

The two products’ registration dates are identical on 20 January 2016, but their expiration dates are different on 26 M...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.